End-of-day quote
Taiwan S.E.
03:30:00 31/05/2024 am IST
|
5-day change
|
1st Jan Change
|
29
TWD
|
-0.68%
|
|
+0.52%
|
+0.52%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,544
|
1,295
|
1,196
|
5,499
|
2,652
|
3,418
|
Enterprise Value (EV)
1 |
2,190
|
2,015
|
1,786
|
5,885
|
2,634
|
3,859
|
P/E ratio
|
15.6
x
|
39.2
x
|
-8.76
x
|
27.3
x
|
22.2
x
|
74.7
x
|
Yield
|
4.29%
|
1.7%
|
-
|
1.02%
|
2.98%
|
1.04%
|
Capitalization / Revenue
|
0.58
x
|
0.56
x
|
0.67
x
|
2.73
x
|
1.15
x
|
1.98
x
|
EV / Revenue
|
0.83
x
|
0.87
x
|
1.01
x
|
2.92
x
|
1.14
x
|
2.24
x
|
EV / EBITDA
|
8.14
x
|
10.2
x
|
9.46
x
|
17.1
x
|
10.2
x
|
18.8
x
|
EV / FCF
|
12.7
x
|
-513
x
|
9.87
x
|
85.3
x
|
-13.8
x
|
-32
x
|
FCF Yield
|
7.9%
|
-0.19%
|
10.1%
|
1.17%
|
-7.24%
|
-3.13%
|
Price to Book
|
1.03
x
|
0.89
x
|
0.94
x
|
3.73
x
|
1.69
x
|
1.86
x
|
Nbr of stocks (in thousands)
|
1,10,250
|
1,10,250
|
1,08,250
|
1,08,250
|
1,08,250
|
1,18,464
|
Reference price
2 |
14.00
|
11.75
|
11.05
|
50.80
|
24.50
|
28.85
|
Announcement Date
|
27/02/19
|
27/02/20
|
16/03/21
|
17/03/22
|
24/02/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,648
|
2,315
|
1,773
|
2,013
|
2,307
|
1,724
|
EBITDA
1 |
268.9
|
198.5
|
188.8
|
343.6
|
258.9
|
205.8
|
EBIT
1 |
112.1
|
35.89
|
11.25
|
159.5
|
66.21
|
3.059
|
Operating Margin
|
4.23%
|
1.55%
|
0.63%
|
7.92%
|
2.87%
|
0.18%
|
Earnings before Tax (EBT)
1 |
129
|
45.16
|
18.91
|
165.5
|
65
|
10.3
|
Net income
1 |
98.86
|
33.26
|
-138.1
|
201.2
|
119.7
|
43.73
|
Net margin
|
3.73%
|
1.44%
|
-7.79%
|
10%
|
5.19%
|
2.54%
|
EPS
2 |
0.8967
|
0.3000
|
-1.261
|
1.859
|
1.106
|
0.3862
|
Free Cash Flow
1 |
173
|
-3.929
|
181
|
68.98
|
-190.6
|
-120.7
|
FCF margin
|
6.53%
|
-0.17%
|
10.21%
|
3.43%
|
-8.26%
|
-7%
|
FCF Conversion (EBITDA)
|
64.34%
|
-
|
95.88%
|
20.08%
|
-
|
-
|
FCF Conversion (Net income)
|
175.01%
|
-
|
-
|
34.28%
|
-
|
-
|
Dividend per Share
2 |
0.6000
|
0.2000
|
-
|
0.5200
|
0.7310
|
0.3000
|
Announcement Date
|
27/02/19
|
27/02/20
|
16/03/21
|
17/03/22
|
24/02/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
647
|
720
|
590
|
386
|
-
|
442
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
18.5
|
-
|
Leverage (Debt/EBITDA)
|
2.404
x
|
3.626
x
|
3.126
x
|
1.123
x
|
-
|
2.146
x
|
Free Cash Flow
1 |
173
|
-3.93
|
181
|
69
|
-191
|
-121
|
ROE (net income / shareholders' equity)
|
6.64%
|
2.12%
|
1.21%
|
9.77%
|
3.07%
|
1.09%
|
ROA (Net income/ Total Assets)
|
2.68%
|
0.88%
|
0.29%
|
4.08%
|
1.52%
|
0.07%
|
Assets
1 |
3,684
|
3,798
|
-47,272
|
4,935
|
7,879
|
65,270
|
Book Value Per Share
2 |
13.60
|
13.20
|
11.70
|
13.60
|
14.50
|
15.50
|
Cash Flow per Share
2 |
0.7100
|
0.4300
|
0.5000
|
1.870
|
2.420
|
1.770
|
Capex
1 |
142
|
262
|
255
|
207
|
476
|
292
|
Capex / Sales
|
5.37%
|
11.32%
|
14.36%
|
10.3%
|
20.64%
|
16.95%
|
Announcement Date
|
27/02/19
|
27/02/20
|
16/03/21
|
17/03/22
|
24/02/23
|
29/02/24
|
|
1st Jan change
|
Capi.
|
---|
| +0.52% | 11Cr | | +2.46% | 10TCr | | -8.98% | 6.08TCr | | +74.76% | 4.89TCr | | +13.97% | 3.8TCr | | +4.56% | 3.24TCr | | +14.72% | 2.06TCr | | +11.17% | 1.66TCr | | +8.81% | 1.39TCr | | -3.19% | 1.32TCr |
Other Commodity Chemicals
|